Publications by authors named "Mitchell R Smith"

100Publications

Understanding the presence of mental fatigue in English academy soccer players.

J Sports Sci 2020 Jul 25;38(13):1524-1530. Epub 2020 Mar 25.

Institute of Sport and Preventive Medicine, Saarland University , Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02640414.2020.1746597DOI Listing
July 2020

Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma.

Bone Marrow Transplant 2020 Jun 30;55(6):1184-1187. Epub 2019 Aug 30.

Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0657-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269903PMC
June 2020

Comparing the Effects of Three Cognitive Tasks on Indicators of Mental Fatigue.

J Psychol 2019 12;153(8):759-783. Epub 2019 Jun 12.

University of Technology Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00223980.2019.1611530DOI Listing
January 2020

Mental Fatigue in Football: Is it Time to Shift the Goalposts? An Evaluation of the Current Methodology.

Sports Med 2019 02;49(2):177-183

Sport and Exercise Discipline Group, Faculty of Health, University of Technology Sydney, Moore Park, NSW, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40279-018-1016-z
Publisher Site
http://dx.doi.org/10.1007/s40279-018-1016-zDOI Listing
February 2019

Optimal use of novel agents in chronic lymphocytic leukemia.

Leuk Res 2018 07 7;70:37-40. Epub 2018 May 7.

Back Bay Biosciences, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.05.001DOI Listing
July 2018

Mental Fatigue and Soccer: Current Knowledge and Future Directions.

Sports Med 2018 07;48(7):1525-1532

Sport and Exercise Discipline Group, Faculty of Health, University of Technology Sydney, Moore Park, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40279-018-0908-2
Publisher Site
http://dx.doi.org/10.1007/s40279-018-0908-2DOI Listing
July 2018

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

N Engl J Med 2017 12 10;377(26):2531-2544. Epub 2017 Dec 10.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.S.N., J.R.W.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (F.L.L., J.C.C.); Washington University and Siteman Cancer Center, St. Louis (N.L.B., A. Ghobadi); University of Miami, Miami (L.J.L., K.V.K.); Stanford University, Stanford (D.B.M., R.L.), City of Hope National Medical Center, Duarte (T.S.), University of California at Los Angeles, Los Angeles (J.M.T.), University of California at San Diego, San Diego (J.E.C.), and Kite Pharma, Santa Monica (A.B., J.R., L.N., Y.J., J.A., M.E., D.C., J.W., W.Y.G.) - all in California; Dana-Farber Cancer Institute, Boston (C.A.J., E.D.J.); Montefiore Medical Center, Bronx (I.B.), and the University of Rochester School of Medicine, Rochester (J.W.F., P.R.) - both in New York; Vanderbilt University Medical Center (O.O.O.) and the Sarah Cannon Research Institute and Tennessee Oncology (I.W.F.), Nashville; Mayo Clinic, Rochester, MN (Y.L., T.E.W.); Loyola University Medical Center, Maywood, IL (P.J.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (A. Goy); Cleveland Clinic, Cleveland (B.T.H., M.R.S.); Karmanos Cancer Center, Wayne State University, Detroit (A.D.); University of Iowa Carver College of Medicine, Iowa City (U.F.); Colorado Blood Cancer Institute, Denver (P.M.S.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (J.M.); and Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (I.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1707447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882485PMC
December 2017

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era.

Clin Lymphoma Myeloma Leuk 2017 Dec 13;17(12):797-803. Epub 2017 Jul 13.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.07.002DOI Listing
December 2017

Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.

Clin Lymphoma Myeloma Leuk 2017 Dec 14;17(12):857-862. Epub 2017 Jul 14.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.07.003DOI Listing
December 2017

A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

Leuk Lymphoma 2018 03 11;59(3):690-694. Epub 2017 Jul 11.

d Department of Internal Medicine, Division of Medical Oncology , University of Washington/Seattle Cancer Care Alliance , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1347932DOI Listing
March 2018

Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma.

Am J Hematol 2017 Oct 19;92(10):989-996. Epub 2017 Jul 19.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, Ohio 44195.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24819DOI Listing
October 2017

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

J Natl Cancer Inst 2017 01 31;109(1). Epub 2016 Dec 31.

Affiliations of authors: Division of Hematology and Medical Oncology, Oregon Health and Science (OHSU) University Knight Cancer Institute, Portland, OR (SES); Clinical Research Division, Fred Hutchinson Cancer Research Center/ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA (BGT, AKG); Department of Medicine, Weill Cornell Medicine, New York, NY (PM, JPL); John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ (AHG); Department of Medicine III, Klinikum der Universität München, Campus Grosshadern, Munich, Germany (MPD); Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (ML); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD (LB); HIV and AIDS Malignancy Branch, Center for Cancer Research, and Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (RFL); Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH (MRS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059122PMC
January 2017

Low Level of Blood CD4 T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2017 02 30;17(2):83-88. Epub 2016 Nov 30.

Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.11.005DOI Listing
February 2017

Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells.

Oncotarget 2016 Oct;7(43):70000-70010

Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342530PMC
October 2016

Clinical approach to diffuse large B cell lymphoma.

Blood Rev 2016 11 30;30(6):477-491. Epub 2016 Jun 30.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2016.06.003DOI Listing
November 2016

Antibody Drug Conjugates (ADCs): Changing the Treatment Landscape of Lymphoma.

Curr Treat Options Oncol 2016 10;17(10):55

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-016-0428-yDOI Listing
October 2016

Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.

Br J Haematol 2017 11 13;179(4):674-676. Epub 2016 Jul 13.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14236DOI Listing
November 2017

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas.

Blood Lymphat Cancer 2016;6:1-6. Epub 2016 Mar 15.

Department of Hematology, Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S73530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929980PMC
March 2016

Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma.

Cancer Res 2016 06 6;76(11):3340-50. Epub 2016 Apr 6.

Department of Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, Ohio. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3099DOI Listing
June 2016

Is rituximab sub-optimally dosed in indolent B cell lymphoma?

Br J Haematol 2016 09 2;174(5):721-9. Epub 2016 May 2.

Department of Medical Oncology and Hematology, Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14114DOI Listing
September 2016

Ibrutinib: a force with a dark side?

Authors:
Mitchell R Smith

Blood 2016 Mar;127(12):1523-4

CLEVELAND CLINIC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-02-694877DOI Listing
March 2016

Mental Fatigue: Impairment of Technical Performance in Small-Sided Soccer Games.

Int J Sports Physiol Perform 2016 Nov 24;11(8):1100-1105. Epub 2016 Aug 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1123/ijspp.2015-0710DOI Listing
November 2016

Mental fatigue impairs soccer-specific decision-making skill.

J Sports Sci 2016 Jul 7;34(14):1297-304. Epub 2016 Mar 7.

a Sport and Exercise Discipline Group, Faculty of Health , University of Technology Sydney (UTS) Sydney Cricket Ground , Moore Park , New South Wales , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02640414.2016.1156241DOI Listing
July 2016

Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia.

Leuk Res 2016 Apr 21;43:9-12. Epub 2016 Feb 21.

Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.02.008DOI Listing
April 2016

Mature answers but new questions in indolent and mantle-cell lymphoma.

Authors:
Mitchell R Smith

Lancet Oncol 2016 Jan 5;17(1):6-8. Epub 2015 Dec 5.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00517-3DOI Listing
January 2016

Mental Fatigue Impairs Soccer-Specific Physical and Technical Performance.

Med Sci Sports Exerc 2016 Feb;48(2):267-76

1Sport and Exercise Discipline Group, Faculty of Health, University of Technology Sydney, AUSTRALIA; 2Department of Movement and Sports Sciences, Faculty of Medicine and Health Sciences, Ghent University, BELGIUM; and 3Endurance Research Group, School of Sport and Exercise Sciences, University of Kent at Medway, UNITED KINGDOM.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000000762DOI Listing
February 2016

Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics.

Oncotarget 2015 Jul;6(19):16912-25

Department of Immunology, Lerner Research Institute, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627281PMC
http://dx.doi.org/10.18632/oncotarget.4857DOI Listing
July 2015

Ibrutinib in B lymphoid malignancies.

Authors:
Mitchell R Smith

Expert Opin Pharmacother 2015 13;16(12):1879-87. Epub 2015 Jul 13.

Taussig Cancer Institute, Cleveland Clinic , 9500 Euclid Avenue, Cleveland, OH , USA +1 216 444 4366 ; +1 216 444 9464 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1067302DOI Listing
November 2015

Progression and Transformation of Clonally Heterogeneous B-cell Lymphoma.

PLoS One 2015 12;10(6):e0130590. Epub 2015 Jun 12.

Computer Services, Physical Sciences Inc., Andover, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0130590PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466348PMC
April 2016

CCMCL1: a new model of aggressive mantle cell lymphoma.

Blood 2015 Apr;125(17):2730-2

Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-01-622795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432548PMC
April 2015

Mental Fatigue Impairs Intermittent Running Performance.

Med Sci Sports Exerc 2015 Aug;47(8):1682-90

1Sport and Exercise Discipline Group, Faculty of Health, University of Technology Sydney, AUSTRALIA; and 2Endurance Research Group, School of Sport and Exercise Sciences, University of Kent at Medway, UNITED KINGDOM.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000000592DOI Listing
August 2015

Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways.

Br J Haematol 2015 Mar 4;168(5):765-8. Epub 2014 Oct 4.

Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13149DOI Listing
March 2015

A phase 1 dose-escalation study of XmAb® 2513 in patients with relapsed or refractory Hodgkin lymphoma.

Br J Haematol 2015 Mar 1;168(6):902-4. Epub 2014 Oct 1.

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13152DOI Listing
March 2015

Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.

Mol Cancer Res 2014 Sep 24;12(9):1205-15. Epub 2014 Jul 24.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163513PMC
September 2014

Allogeneic transplantation for lymphoma: risk-benefit balance is in the eye of the beholder.

Authors:
Mitchell R Smith

Biol Blood Marrow Transplant 2014 Jul 14;20(7):905-6. Epub 2014 May 14.

Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.007DOI Listing
July 2014

Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotin.

Leuk Lymphoma 2015 May;56(5):1552-3

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.911865DOI Listing
May 2015

Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.

J Clin Oncol 2014 Apr 24;32(12):1242-8. Epub 2014 Mar 24.

Thomas Prebet, James Herman, Lisa Malick, and Steven D. Gore, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Zhuoxin Sun, Dana-Farber Cancer Institute, Boston, MA; Maria E. Figueroa and Ari Melnick, Weill Cornell Medical College; Janice Gabrilove, Mount Sinai School of Medicine; Martin S. Tallman, Leukemia Service, Memorial Sloane-Kettering Cancer Center, New York; Elisabeth Paietta, North Division, Montefiore Medical Center, Bronx, NY; Rhett Ketterling and Mark Litzow, Mayo Clinic, Rochester, MN; Peter L. Greenberg, Stanford University Cancer Center, Stanford, CA; Mark Juckett, University of Wisconsin, Madison, WI; Mitchell R. Smith, Fox Chase Cancer Center, Philadelphia, PA; Magdalena Czader, Indiana University Cancer Center, Indianapolis, IN; and Harry P. Erba, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.3102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986386PMC
April 2014

Milatuzumab and veltuzumab induce apoptosis through JNK signalling in an NF-κB dependent human transformed follicular lymphoma cell line.

Br J Haematol 2014 Apr 6;165(1):151-3. Epub 2014 Jan 6.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12711DOI Listing
April 2014

New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals.

Discoveries (Craiova) 2014 Jan-Mar;2(1)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15190/d.2014.6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535816PMC
August 2015

Is early hematopoietic stem-cell transplantation necessary in mantle-cell lymphoma?

Authors:
Mitchell R Smith

J Clin Oncol 2014 Feb 16;32(4):265-7. Epub 2013 Dec 16.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.2762DOI Listing
February 2014

Novel targeted therapies in peripheral T cell lymphoma.

Discov Med 2013 Jun;15(85):367-78

Department of Hematological Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
June 2013

Therapies for mantle cell lymphoma: current challenges and a brighter future.

Discov Med 2013 Mar;15(82):177-87

Temple-Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
March 2013

Dose dependent effects on cell cycle checkpoints and DNA repair by bendamustine.

PLoS One 2012 29;7(6):e40342. Epub 2012 Jun 29.

Basic Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0040342PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386996PMC
November 2012

Radioimmunotherapy in mantle cell lymphoma.

Best Pract Res Clin Haematol 2012 Jun 9;25(2):201-10. Epub 2012 May 9.

Fox Chase Cancer Center, 333 Cottman Avenue, PA 19111, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216926120003
Publisher Site
http://dx.doi.org/10.1016/j.beha.2012.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748580PMC
June 2012

Tetanus toxoid reactive lymphadenopathy masquerading as T-cell lymphoma.

Future Oncol 2012 May;8(5):631-4

Dept of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.12.37DOI Listing
May 2012

Lacrimal gland lymphoma: Role of radiation therapy.

Oman J Ophthalmol 2012 Jan;5(1):37-41

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0974-620X.94765DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339673PMC
January 2012

Brentuximab vedotin in anaplastic large cell lymphoma.

Expert Opin Biol Ther 2012 May 27;12(5):633-9. Epub 2012 Mar 27.

Department of Medical Oncology, Lymphoma Service, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2012.673578DOI Listing
May 2012

Should there be a standard therapy for mantle cell lymphoma?

Authors:
Mitchell R Smith

Future Oncol 2011 Feb;7(2):227-37

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, PA 19111 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.189DOI Listing
February 2011

Gastric mucosa-associated lymphoid tissue lymphoma.

Semin Oncol 2010 Jun;37(3):183-7

Hematology and Oncology Associates of Northeastern PA, PC, 1100 Meade St, Dunmore, PA 18512, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2010.05.013DOI Listing
June 2010

Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation.

Stem Cells Cloning 2010 Jul 7;3:93-102. Epub 2010 Jul 7.

Department of Medical Oncology, Fox Chase Cancer Center, Temple University, Philadelphia, PA, USA ; Division of Bone Marrow Transplantation, Temple University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781733PMC
http://dx.doi.org/10.2147/sccaa.s7016DOI Listing
July 2010

Pediatric nodal marginal zone lymphoma may develop in the adult population.

Leuk Lymphoma 2010 Jan;51(1):89-94

Department of Medical Oncology, Fox Chase Cancer Center, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903349670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572776PMC
January 2010

Immunotherapy of cancer.

Eur J Pharmacol 2009 Dec 20;625(1-3):41-54. Epub 2009 Oct 20.

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001429990900890
Publisher Site
http://dx.doi.org/10.1016/j.ejphar.2009.09.067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783916PMC
December 2009

Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines.

Clin Cancer Res 2009 Apr 7;15(8):2808-17. Epub 2009 Apr 7.

Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681251PMC
April 2009

Review: lymphomatoid granulomatosis: challenges in diagnosis and treatment.

Clin Adv Hematol Oncol 2009 Jan;7(1):68-70

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
January 2009

Mantle cell lymphoma: advances in biology and therapy.

Authors:
Mitchell R Smith

Curr Opin Hematol 2008 Jul;15(4):415-21

Lymphoma Service, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328302c9c5DOI Listing
July 2008

Antibodies and hematologic malignancies.

Authors:
Mitchell R Smith

Cancer J 2008 May-Jun;14(3):184-90

Lymphoma Service, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318173a5f9DOI Listing
September 2008

Bortezomib sensitizes non-Hodgkin's lymphoma cells to apoptosis induced by antibodies to tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors TRAIL-R1 and TRAIL-R2.

Clin Cancer Res 2007 Sep;13(18 Pt 2):5528s-5534s

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0982DOI Listing
September 2007

Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.

Cancer Res 2007 Sep;67(18):8923-31

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-2153DOI Listing
September 2007

Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature.

Leuk Lymphoma 2006 Sep;47(9):1902-7

Department of Medical Oncology, Temple University Hospital, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600688099DOI Listing
September 2006